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Short Communication
About 22,000 samples of oral fluid have been collected in five
population studies in Norway using either the Intercept® or
Statsure™ oral fluid sampling devices. The prevalence of alcohol
and drugs was found to be higher in oral fluid samples with small
volumes than in those with large volumes for both sampling
devices; the largest differences were observed for
tetrahydrocannabinol, alcohol, amphetamines, and
cocaine/benzoylecgonine when using the Statsure device. Our
recommendation is that samples of oral fluid with smaller volume
than required by the analytical methods should not be discarded,
but instead be analyzed using a smaller sample volume, if
necessary, after dilution. If not analyzed, positive drug cases will
be missed, and the total prevalence of alcohol and drugs in the
population being studied will be underestimated.
Introduction
A number of medicinal drugs (1,2) and illegal drugs (3–6)
may reduce salivary flow and cause short-term hyposalivation
or chronic xerostomia. In these cases, the volume of oral fluid
collected using a commercially available sampling device may
be small and in some cases less than the volume required by
the analytical methods.
A roadside survey of alcohol, drugs, and driving was per-
formed in Norway in 2005–2006 using the Intercept® Oral
Specimen Sampling Device (Orasure Technologies, Bethlehem,
PA) to collect samples of oral fluid (7). A second study was
performed 2008–2009 as part of the European DRUID project
using Statsure Saliva Sampler™ (Saliva Diagnostic Systems,
Framingham, MA). In addition, we have performed three other
population studies using oral fluid collected with the Statsure
device during 2008–2010. Drug findings for different oral fluid
sample volume intervals are presented in this report.
Materials and Methods
Samples of oral fluid were collected using the Intercept Oral
Specimen Collection Device or the Statsure Saliva Sampler.
The collection time for the Intercept device was 2 min, and for
the Statsure device, collection was performed until the volume
indicator turned blue or for a maximum of 5 min if the indi-
cator did not turn blue. The Intercept and Statsure devices con-
tained 0.8 and 1.0 mL buffer, respectively. The collected vol-
umes of oral fluid were determined for each sample by
weighing.
Alcohol was determined by an automated enzymatic
method (8) using 100 µL oral fluid/buffer mixture. Drugs
were extracted from 500 µL oral fluid/buffer mixture using
liquid–liquid extraction and analyzed with liquid chro-
matography with tandem mass spectroscopic detection (9). In
cases where less than 500 µL oral fluid/buffer mixture was
available for analytical testing, smaller volumes were ex-
tracted with the same amount of solvent after adding the
regular volume of internal standard solution and buffer, as
stated in the analytical method. Samples with volumes less
than 100 µL were not analyzed; these were regarded as failed
oral fluid sample collections.
The dilution of native oral fluid was expected to be different
for the two sampling devices. For the Intercept device, the
manufacturer stated that an average of 0.4 mL oral fluid would
be collected, which would be diluted with 0.8 mL buffer present
in the sampling device. For the Statsure device, an average of
1.0 mL oral fluid was expected to be collected, which would be
diluted with 1.0 mL buffer. Different analytical cut-off thresh-
olds were therefore used for the two devices in an attempt to
obtain comparable results. However, for alcohol and some
drugs we needed to use lower cut-off values to comply with re-
quirements set by the DRUID project. All analytical cut-off
thresholds were equal to or larger than the quantification
limits of the analytical methods. The same cut-off thresholds
were used for high-volume and low-volume samples.
Reporting thresholds for drug concentrations in undiluted
oral fluid were set based on a combination of analytical capa-
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bilities and expected pharmacologically relevant thresholds
(7). Analytical cut-off and reporting thresholds are presented in
Table I.
Pearson’s two-sided chi square test for categorical data was
calculated using SPSS (version 14.0, Chicago, IL) and used for
the statistical evaluation of findings.
Table I. Analytical Cut-Off and Reporting Thresholds
Analytical Cut-Off Thresholds for
ReportingOral Fluid/Buffer Mixtures
Thresholds for(ng/mL)
Undiluted Oral Fluid
Substance Intercept Statsure (ng/mL)
Alcohol 0.05 mg/mL 0.05 mg/mL 0.1 mg/mL
Alprazolam 0.15 0.23 1
Amphetamine 9.1 12.2 25
Benzoylecgonine 2.4 3.6 10
Carisoprodol 8.6 13.0 50
Clonazepam 0.16 0.24 0.5
Cocaine 0.61 0.91 10
Codeine 2.5 3.7 20
Diazepam 0.24 0.18 1
Flunitrazepam 0.10 0.16 0.3
Lorazepam 0.55 0.48 1.6
Meprobamate 7.2 10.9 1000
Methadone 2.6 3.9 20
Methamphetamine 4.9 7.5 25
Morphine 2.4 3.6 10
Nitrazepam 0.14 0.21 0.5
Nordiazepam 0.22 0.34 1
Oxazepam 1.4 2.4 5
Tetrahydrocannabinol (THC) 0.26 0.31 1
Zolpidem 0.05 0.08 10
Zopiclone 0.32 0.49 10
3,4-Methylenedioxyamphetamine (MDA) Not analyzed 9.0 25
3,4-Methylenedioxy-N-ethylamphetamine (MDEA) 6.8 10.3 25
3,4-Methylenedioxy-N-methylamphetamine (MDMA) 1.6 1.9 25
6-Monoacetylmorphine 0.27 0.41 5
Table II. Prevalence (%) of Alcohol and Drugs Within Different Volume Intervals of Oral Fluid Collected with the Intercept
Oral Specimen Collection Device
Oral Fluid Volume < 0.20 mL 0.20–0.29 mL 0.30–0.39 mL 0.40–0.59 mL ≥ 0.60 mL p
No. of samples 2451 2700 1779 2098 1788 —
Alcohol or drugs 6.3 4.8 4.2 3.5 3.4 < 0.001
Alcohol 0.7 0.4 0.1 0.3 0.2 0.005
Medicinal drugs* 4.2 3.3 3.5 2.9 2.8 0.067
Zopiclone 2.0 1.4 1.7 1.1 1.3 0.173
Diazepam or nordiazepam 1.1 0.7 0.8 0.7 0.8 0.424
Illegal drugs† 1.9 1.1 0.8 0.4 0.5 < 0.001
Amphetamines 0.4 0.3 0.2 0.1 0.2 0.347
Cocaine or benzoylecgonine 0.1 0.2 0.1 0.1 0.1 0.551
THC 1.5 0.6 0.6 0.1 0.2 < 0.001
* Includes alprazolam, carisoprodol, clonazepam, codeine, diazepam, flunitrazepam, lorazepam, meprobamate, methadone, morphine, nitrazepam, nordiazepam,
oxazepam, zolpidem, and zopiclone.
† Includes amphetamine, benzoylecgonine, cocaine, methamphetamine, THC, MDA, MDEA, MDMA, and 6-monoacetylmorphine.
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Results and Discussion
A total of 10,816 samples of oral fluid samples collected with
the Intercept device were analyzed. These samples contained
collected oral fluid mixed with 0.8 mL buffer present in the
sampling device. The oral fluid/buffer mixture was recovered
from the device by centrifugation of the sample tube. Practi-
cally all the oral fluid/buffer mixture was recovered and avail-
able for analytical testing. The average volume of collected
oral fluid was 0.34 mL. If only 0.2 mL oral fluid was collected,
1.0 mL oral fluid/buffer mixture was available for analytical
testing. Results for alcohol, medicinal drugs, illegal drugs, and
some of the most prevalent drugs or drug groups in undiluted
oral fluid were calculated, and findings in relation to original
sample volume are presented in Table II.
A total of 10,928 samples of oral fluid collected with the
Statsure device were analyzed. These samples contained col-
lected oral fluid mixed with 1.0 mL buffer. Before analytical
testing, the sampling pad was disconnected from the sampling
pad stem and placed into the sample tube, and a filter tube was
inserted into the sample tube to recover
the oral fluid/buffer mixture. However,
about 1.0 mL oral fluid/buffer mixture
could not be recovered and remained in
the sample tube absorbed by the sampling
pad. Thus, if 0.2 mL oral fluid was col-
lected, only about 0.2 mL oral fluid/buffer
mixture was recovered from the sampling
device. Therefore, either alcohol or drugs
were analyzed in samples with volumes
between 0.1 and 0.2 mL oral fluid/buffer
mixture. The average volume of collected
oral fluid was 0.90 mL when using the
Statsure device. Analytical results are pre-
sented in Table III.
For both sampling devices, higher
prevalences of alcohol and drugs were
found among oral fluid samples with
small volumes. The prevalence decreased
with increasing sample volume but was
statistically significant for a larger number of substances when
using the Statsure sampling device than when using the In-
tercept device. Particularly large differences between small-
and large-volume samples were observed for tetrahydro-
cannabinol (THC), alcohol, amphetamines, and cocaine/ben-
zoylecgonine using the Statsure device. Less marked differ-
ences were observed for medicinal drugs.
The average volume of collected oral fluid in relation to
substance findings are presented in Table IV. The average vol-
umes of oral fluid were lower in samples where alcohol or
some drugs were found, especially for the Statsure device.
The Intercept sampling pad is made of cotton treated with a
solution containing sodium chloride, citric acid, sodium ben-
zoate, potassium sorbate, gelatine, and sodium hydroxide, ac-
cording to the package insert; it thus contains chemicals that
stimulate the production of oral fluid. The Statsure sampling
pad is made with cellulose and is not treated with any chemi-
cals stimulating the production of saliva does not (10). Chem-
ical stimulation of oral fluid production did not eliminate the
higher prevalence of drugs and alcohol in small-volume sam-
Table III. Prevalence (%) of Alcohol and Drugs Within Different Volume Intervals of Oral Fluid Collected with the Statsure
Saliva Sampler
Oral Fluid Volume < 0.50 mL 0.50–0.74 mL 0.75–0.99 mL 1.00–1.24 mL ≥ 1.25 mL p
No. of samples 1202 1122 4069 3999 536 –
Alcohol or drugs 18.1 6.4 4.4 2.7 3.0 < 0.001
Alcohol 4.5 0.9 0.3 0.3 0.4 < 0.001
Medicinal drugs 9.3 3.7 3.1 2.0 2.4 < 0.001
Zopiclone 3.0 1.4 1.2 0.7 1.1 < 0.001
Diazepam or nordiazepam 3.9 1.2 1.0 0.8 0.7 < 0.001
Illegal drugs 9.7 2.9 1.5 0.7 0.6 < 0.001
Amphetamines 4.2 0.8 0.5 0.2 0.4 < 0.001
Cocaine or benzoylecgonine 2.3 0.5 0.2 0.2 0.0 < 0.001
THC 6.5 2.7 1.1 0.4 0.2 < 0.001
Table IV. Average Volumes (mL) of Oral Fluid Collected in Relation to Sampling
Device and Substance Findings
Intercept Statsure
Substance Volume (mL) n Volume (mL) n
No substance found 0.35 10,302 0.91 10,355
Alcohol or drugs 0.30 492 0.67 592
Alcohol 0.25 38 0.44 87
Medicinal drugs 0.32 365 0.74 365
Zopiclone 0.31 163 0.75 134
Diazepam or nordiazepam 0.32 87 0.71 133
Illegal drugs 0.26 110 0.58 240
Amphetamines 0.31 31 0.52 86
Cocaine or benzoylecgonine 0.34 14 0.55 50
THC 0.21 69 0.57 168
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ples; however, the difference between small- and large-volume
samples was smaller.
Our findings suggest that oral fluid samples with volume less
than normally required by the analytical methods should not
be excluded from alcohol and drug analysis. In cases where
small volumes of oral fluid/buffer mixture are available, sam-
ples should be analyzed, if necessary, after diluting the samples,
and smaller samples volumes or dilutions should be corrected
for in later calculations. This recommendation applies when
using the Statsure device because the Intercept device does not
have the same problem of retained liquid that is not available
for analytical testing.
In some cases with small volume of oral fluid, the dilution
with buffer may cause drug concentrations below the analytical
cut-off, even if the concentration in native oral fluid is high.
However, we experienced that the drug concentrations in many
of the small-volume samples were high in spite of the large di-
lution with buffer. This was, in many cases, due to the use of
large doses of drugs that are known to cause hyposalivation.
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